1. Home
  2. EFOI vs BLRX Comparison

EFOI vs BLRX Comparison

Compare EFOI & BLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energy Focus Inc.

EFOI

Energy Focus Inc.

HOLD

Current Price

$2.25

Market Cap

14.9M

ML Signal

HOLD

Logo BioLineRx Ltd.

BLRX

BioLineRx Ltd.

HOLD

Current Price

$2.93

Market Cap

12.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFOI
BLRX
Founded
1985
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.9M
12.9M
IPO Year
1994
2011

Fundamental Metrics

Financial Performance
Metric
EFOI
BLRX
Price
$2.25
$2.93
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$19.00
AVG Volume (30 Days)
19.2K
23.2K
Earning Date
11-12-2025
11-24-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,863,000.00
$12,735,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.19
$2.30
52 Week High
$3.56
$14.70

Technical Indicators

Market Signals
Indicator
EFOI
BLRX
Relative Strength Index (RSI) 48.12 39.72
Support Level $2.30 $2.85
Resistance Level $2.57 $3.03
Average True Range (ATR) 0.29 0.17
MACD 0.03 -0.02
Stochastic Oscillator 35.05 18.39

Price Performance

Historical Comparison
EFOI
BLRX

About EFOI Energy Focus Inc.

Energy Focus Inc engages in the design, development, manufacturing, marketing, and sale of energy-efficient lighting systems and controls. The company serves the military maritime market and general commercial markets. Its product offerings include Military maritime LED lighting products such as military intelligible, globe lights, berth lights, and military fixtures and Commercial products such as LED fixtures and panels, LED down-lights, LED dock lights, and LED retrofit kits. Geographically, it operates in the United States and other countries. Its products include commercial products and MMM products. The company generates a majority of its sales from Military maritime products in the United States.

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

Share on Social Networks: